We’re thrilled to announce that 3billion, founded in 2016 as an AI-driven rare disease diagnostic company, is now officially listed on KOSDAQ, South Korea’s stock exchange for innovative and growing companies. This achievement marks an important milestone in strengthening our global presence and advancing our commitment to innovation in rare disease diagnostics.
Moving forward, 3billion will continue to empower healthcare professionals worldwide with our proprietary AI technology to deliver fast, accurate diagnoses to patients. We are ready to embark on this exciting journey of growth and global impact!
Join us as we take the next big leap in rare disease diagnostics.
답글 남기기
댓글을 달기 위해서는 로그인해야합니다.